Indo National Limited Acquires 54.79% Stake in Medcuore Medical Solutions for ₹6.94 Crores
Indo National Limited has acquired a 54.79% controlling stake in Medcuore Medical Solutions Private Ltd for ₹6.94 crores, making it a subsidiary. The target company operates in air monitoring systems and air purifiers business with FY25 turnover of ₹35.41 lakhs. The acquisition aims to facilitate business growth and revenue generation through expansion into new business segments, with completion expected by FY 2027-28.

*this image is generated using AI for illustrative purposes only.
Indo National Limited has successfully acquired a controlling stake in Medcuore Medical Solutions Private Ltd (MMSPL) through a strategic investment of ₹6.94 crores. The acquisition, completed through equity share subscription, gives Indo National a 54.79% shareholding in MMSPL on a fully diluted basis, effectively making it a subsidiary.
Investment Details
The company disclosed the investment details in its regulatory filing dated January 22, 2026, pursuant to Regulation 30 of SEBI LODR requirements. The acquisition involved purchasing 7,551 equity shares at a price of ₹9,187.00 per share, determined based on a valuation report issued by a registered valuer.
| Parameter: | Details |
|---|---|
| Total Investment: | ₹6,93,66,540 |
| Shareholding Acquired: | 54.79% |
| Number of Shares: | 7,551 shares |
| Price per Share: | ₹9,187.00 |
| Consideration Type: | Cash |
Target Company Profile
Medcuore Medical Solutions Private Ltd, incorporated on June 7, 2020, operates in the manufacturing, distribution, and servicing of air monitoring systems and air purifiers. The company has shown varying revenue performance over the past three years, with operations concentrated in India.
Financial Performance Overview
| Financial Year: | Turnover |
|---|---|
| FY 2025: | ₹35,41,484 |
| FY 2024: | ₹47,68,000 |
| FY 2023: | ₹83,54,000 |
Strategic Rationale
Indo National stated that the acquisition aims to facilitate business growth, generate revenue, and earn profits through business expansion. The move represents a diversification into the air monitoring and purification sector, which falls outside the company's main line of business. The acquisition is structured as a non-related party transaction, with no promoter or group company interests in the target entity.
Regulatory and Timeline Aspects
The acquisition requires no additional governmental or regulatory approvals beyond standard compliance requirements. Indo National has indicated an indicative completion timeframe extending up to FY 2027-28 for the full acquisition process. The transaction was conducted at arm's length with proper valuation procedures followed as per regulatory guidelines.
This strategic acquisition positions Indo National to expand its business portfolio into the growing air quality monitoring and purification market while maintaining compliance with all applicable securities regulations and disclosure requirements.
Historical Stock Returns for Indo National
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.66% | +0.78% | -0.05% | -13.67% | -24.81% | +20.06% |



































